Logo image of KZIA

KAZIA THERAPEUTICS-SPON ADR (KZIA) Stock Analyst Ratings

NASDAQ:KZIA - Nasdaq - US48669G2049 - ADR - Currency: USD

1.18  +0.33 (+39.63%)

After market: 1.1103 -0.07 (-5.91%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to KZIA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 11.27. This target is 855.17% above the current price.
KZIA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about KZIA.
In the previous month the buy percentage consensus was at a similar level.
KZIA was analyzed by 7 analysts. More opinions would make the average more meaningful.
KZIA Historical Analyst RatingsKZIA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -50 -45 -40 -35 -30 -25 -20 -15 -10 -5 0 2 4 6

Price Target & Forecast

Price Low Median Mean High 1.183.0311.2711.2720.06 - 156.78% 855.17% 855.17% 1,599.58%
KZIA Current Analyst RatingKZIA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-02-06 Maxim Group Initiate Buy
2024-07-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-04-11 HC Wainwright & Co. Upgrade Neutral -> Buy
2022-08-02 Maxim Group Downgrade Buy -> Hold
2022-08-02 HC Wainwright & Co. Downgrade Buy -> Neutral
2021-10-14 Maxim Group Initiate Buy